Targeted Therapy

What is Abemaciclib? Abemaciclib (pronounced ab-em-a-SYE-klib), marketed as Verzenio, is a targeted therapy used to treat: It is typically combined with hormone therapy (fulvestrant or an aromatase inhibitor). How Does Abemaciclib Work? Abemaciclib is a CDK4/6 inhibitor, meaning it blocks proteins (cyclin-dependent kinases 4 & 6) that help cancer cells grow and divide. By inhibiting these proteins, it slows or stops cancer progression. […]